1989
DOI: 10.1016/0020-7292(89)90090-8
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of ampicillin plus sulbactam versus clindamycin and gentamicin for treatment of postpartum infection

Abstract: Thirty‐six hospitalized patients, 18 in each of two groups, with postpartum upper genital tract infection were enrolled in a randomized, prospective study comparing treatment with sulbactam/ampicillin, to treatment with clindamycin/gentamicin. One (5.5%) clinical failure was reported in each group. Side effects were minimal in both groups and did not warrant discontinuation of treatment. The in vitro activity of ampicillin versus sulbactam/ampicillin (1: 2) was evaluated and these data were compared with data … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1991
1991
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Numerous studies in the late 1980s and early 1990s demonstrated that AMS was an effective therapy for the treatment of post-operative infections, pelvic inflammatory disease and post-Caesarean and post-partum endometritis, with equivalent clinical efficacy to comparator agents (81-95% vs. 83-95%), including metronidazole/gentamicin, cefoxitin, cefoxitin/doxycycline, gentamicin/clindamycin and clindamycin alone [64][65][66][67][68][69][70][71][72].…”
Section: Gynaecological Infectionsmentioning
confidence: 99%
“…Numerous studies in the late 1980s and early 1990s demonstrated that AMS was an effective therapy for the treatment of post-operative infections, pelvic inflammatory disease and post-Caesarean and post-partum endometritis, with equivalent clinical efficacy to comparator agents (81-95% vs. 83-95%), including metronidazole/gentamicin, cefoxitin, cefoxitin/doxycycline, gentamicin/clindamycin and clindamycin alone [64][65][66][67][68][69][70][71][72].…”
Section: Gynaecological Infectionsmentioning
confidence: 99%
“…46,59 In phase II, 530 articles were reviewed, of which 38 provided genus or speciated information related to organisms identified by endometrial culture at the time of diagnosis (before antibiotic treatment). We identified 38 studies 17,18,21,22,25,29,30,33,34,36,37,40,42,44,46,48,49,51,55,[57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73] that reported pathogens from endometrial samples of patients with a clinical diagnosis of postpartum endometritis. We then generated a list of the most common 20 genus and family ( Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, many intravenous regimens demonstrated high numbers of patients clinically cured (Table 1). When data from all studies were aggregated, multiple single-agent antibiotics reached the 85% clinical cure threshold: amoxicillin-clauvulanate, 17 ampicillinsulbactam, 17,[32][33][34][35][36][37] aztreonam, 20 cefotaxime, 38-40 cefotetan, 32,41-45 ceftazidime, 46 chloramphenicol, 47 clindamycin, 36,47 ertapenem, 48 imipenem-cilastatin, 49 meropenem, 50 mezlocillin, [51][52][53] piperacillin, 54,55 Unauthorized reproduction of this article is prohibited.…”
Section: Resultsmentioning
confidence: 99%
“…6,7 In August 2009, DHMC adopted the treatment regimen summarized in Figure 2 for IAI and early-onset PPE for all patients not allergic to penicillin, regardless of delivery method (vaginal vs cesarean) and regardless of time of onset of IAI or PPE. Treatment involves intravenous administration of ampicillin/sulbactam until the patient has been afebrile for 24 hours.…”
Section: Introductionmentioning
confidence: 99%